The Current Ratio as of December 2025 (TTM) for Sofiva Genomics Co.,Ltd. (6615.TWO) is 2.90

According to Sofiva Genomics Co.,Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.90. This represents a change of -7.11% compared to the average of 3.12 of the last 4 quarters.

Sofiva Genomics Co.,Ltd. (6615.TWO) Historical Current Ratio (quarterly & annually)

How has 6615.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Sofiva Genomics Co.,Ltd. over the last ten years is 2.52. The current 2.90 Current Ratio has changed 11.43% with respect to the historical average. Over the past ten years (40 quarters), 6615.TWO's Current Ratio was at its highest in in the September 2024 quarter at 3.31. The Current Ratio was at its lowest in in the December 2022 quarter at 0.

Sofiva Genomics Co.,Ltd. (6615.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sofiva Genomics Co.,Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sofiva Genomics Co.,Ltd. (6615.TWO) Average Current Ratio

How has 6615.TWO Current Ratio performed in the past?

The current Current Ratio of Sofiva Genomics Co.,Ltd. (6615.TWO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Sofiva Genomics Co.,Ltd. (6615.TWO) Current Ratio vs. Peers

How is 6615.TWO’s Current Ratio compared to its peers?

Sofiva Genomics Co.,Ltd.’s Current Ratio is less than Bioray Biotech Co., Ltd (7.15), greater than TFBS Bioscience Inc. (2.43), less than Original BioMedicals Co., Ltd. (13.55), less than TaiwanJ Pharmaceuticals Co., Ltd. (18.85), less than Health & Life Co., Ltd. (3.27), less than Vectorite Biomedical Inc. (13.46), greater than EBM Technologies Incorporated (1.14), greater than Welgene Biotech Co.,Ltd. (2.51), greater than Sunder Biomedical Tech. Co., Ltd. (1.33), less than AmCad BioMed Corporation (24.52),

Build a custom stock screener for Sofiva Genomics Co.,Ltd. (6615.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sofiva Genomics Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sofiva Genomics Co.,Ltd. (6615.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sofiva Genomics Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.